Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1992-04-27
1993-11-23
Wax, Robert A.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530380, 530416, 530413, 530415, C07K 322, C07K 318, C07K 320, C07K 328
Patent
active
052645495
ABSTRACT:
A purified protein, factor J, which has inhibitory properties which prevent the formation or the dissociation of Cl complex and a method of purification for said protein. The method including the following sequential chromatography steps: anion exchange, QAE-"SEPHADEX", heparin-"SEPHAROSE" affinity, "MONO Q" and hydroxylapatite.
REFERENCES:
patent: 4147801 (1979-04-01), Lenhard et al.
patent: 4388232 (1983-06-01), Eibl et al.
patent: 4883784 (1989-11-01), Kaneko
patent: 4915945 (1990-04-01), Pelzer et al.
patent: 5109114 (1992-04-01), Nicholson-Weller
Sofer et al. 1983, Bio/Techniques, Nov./Dec., pp. 198-203.
Cooper, "The Classical Complement Pathway: Activation and Regulation of the First Complement Component" 37 Adv. Immunol 151-216 (1985).
Schumaker et al., "Activation of the First Component of Complement" 5 Ann. Rev. Immunol. 21-42 (1987).
Reid et al., "The Proteologic Activation Systems of Complement" 50 Ann. Rev. Biochem. 433-464 (1981).
Ziccardi, "The Role of Immune Complexes in the Activation of the First Component of Human Complement" 132 J. Immunol. 282-288 (1984).
Ziccardi, "Demonstration of the Interaction of Native C1 with Monomeric Immunoglobulins and C1 Inhibitor" 134 J. Immunol. 2559-2563 (1985).
Silvestri et al., "The C1q Inhibitor in Serum is a Chondroitin 4-Sulfate Proteoglycan" 256 J. Biol. Chem. 7383-7387 (1981).
Ghebrehiwet "Clq Inhibitor (C1qINH): Functional Properties and Possible Relationship to a Lymphocyte Membrane-Associated Cq1 Precipitin" 126 J. Immunol. 1837-1842 (1981).
Ghebrehiwet, "Purification and Partial Characterization of a C1q Inhibitor from the Membranes of Human Peripheral Blood Lymphocytes" 129 J. Immunol. 151-162 (1982).
Davis, "C1 Inhibitor and Hereditary Angioneurotic Edema" 6 Ann. Rev. Immunol. 595-628 (1988).
Lopez-Transcasa et al., 1989, J. Biol. Chem. 264(27): 16714-16221.
Abstract, Biosis No. 2064952 of Cheung et al. 1986, Biochem Biophys Acta 882(2):200-209.
Ghebrehiwet et al., 1988, J. Immunol. Methods 110:251-260.
Furman Keith C.
The Beth Israel Hospital Association
Wax Robert A.
LandOfFree
Characterization and method of isolation of factor J, an inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Characterization and method of isolation of factor J, an inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Characterization and method of isolation of factor J, an inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1850067